New Journal Website is available at: http://www.journalonweb.com/rcm

Published by: Neoscriber Demo Publisher

Do Cardiometabolic Risk Factors Relative Risks Differ for the Occurrence of Ischemic Heart Disease and Stroke?

Samaneh Aalami Harandi 1 , Nizal Sarrafzadegan 2 , * , Masoumeh Sadeghi 3 , Mohammad Talaei 2 , Mino Dianatkhah 1 , Shahram Oveisgharan 2 , Ali Pourmoghaddas 4 , Asma Salehi 4 and Zohre Sedighifard 4
Authors Information
1 Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, IR Iran
2 Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, IR Iran
3 Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, IR Iran
4 Department of Cardiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran
Article information
  • Research in Cardiovascular Medicine: February 2016, 5 (1); e30619
  • Published Online: January 6, 2016
  • Article Type: Research Article
  • Received: June 13, 2015
  • Accepted: July 19, 2015
  • DOI: 10.5812/cardiovascmed.30619

To Cite: Aalami Harandi S, Sarrafzadegan N, Sadeghi M, Talaei M, Dianatkhah M, et al. Do Cardiometabolic Risk Factors Relative Risks Differ for the Occurrence of Ischemic Heart Disease and Stroke?, Res Cardiovasc Med. 2016 ;5(1):e30619. doi: 10.5812/cardiovascmed.30619.

Abstract
Copyright: Copyright © 2016, Research in Cardiovascular Medicine. .
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Tunstall-Pedoe H. Preventing Chronic Diseases. A Vital Investment: WHO Global Report. Geneva: World Health Organization, 2005. pp 200. CHF 30.00. ISBN 92 4 1563001. Also published on http://www. who. int/chp/chronic_disease_report/en. Int J Epidemiol. 2006; 35(4): 1107
  • 2. Motlagh B, O'Donnell M, Yusuf S. Prevalence of cardiovascular risk factors in the Middle East: a systematic review. Eur J Cardiovasc Prev Rehabil. 2009; 16(3): 268-80[DOI][PubMed]
  • 3. Talaei M, Sadeghi M, Marshall T, Thomas GN, Iranipour R, Nazarat N, et al. Anthropometric indices predicting incident type 2 diabetes in an Iranian population: the Isfahan Cohort Study. Diabetes Metab. 2013; 39(5): 424-31[DOI][PubMed]
  • 4. Talaei M, Sadeghi M, Mohammadifard N, Shokouh P, Oveisgharan S, Sarrafzadegan N. Incident hypertension and its predictors: the Isfahan Cohort Study. J Hypertens. 2014; 32(1): 30-8[DOI][PubMed]
  • 5. Talaei M, Sarrafzadegan N, Sadeghi M, Oveisgharan S, Marshall T, Thomas GN, et al. Incidence of cardiovascular diseases in an Iranian population: the Isfahan Cohort Study. Arch Iran Med. 2013; 16(3): 138-44[PubMed]
  • 6. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42(2): 517-84[DOI][PubMed]
  • 7. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18): 1837-47[PubMed]
  • 8. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991; 22(3): 312-8[PubMed]
  • 9. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67(5): 968-77[PubMed]
  • 10. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA. 1979; 241(19): 2035-8[DOI]
  • 11. McBride PE. The health consequences of smoking. Cardiovascular diseases. Med Clin North Am. 1992; 76(2): 333-53[PubMed]
  • 12. Rodgers A, MacMahon S. Blood pressure and the global burden of cardiovascular disease. Clin Exp Hypertens. 1999; 21(5-6): 543-52[PubMed]
  • 13. Sadeghi M, Talaei M, Parvaresh Rizi E, Dianatkhah M, Oveisgharan S, Sarrafzadegan N. Determinants of incident prediabetes and type 2 diabetes in a 7-year cohort in a developing country: The Isfahan Cohort Study 72. J Diabetes. 2015; 7(5): 633-41[DOI][PubMed]
  • 14. Sarrafzadegan N, Gharipour M, Sadeghi M, Khosravi AR, Tavassoli AA. Metabolic syndrome in Iranian elderly. ARYA Atheroscler. 2012; 7(4): 157-61[PubMed]
  • 15. Kannel WB, D'Agostino RB, Sullivan L, Wilson PW. Concept and usefulness of cardiovascular risk profiles. Am Heart J. 2004; 148(1): 16-26[DOI][PubMed]
  • 16. Shimamoto T, Komachi Y, Inada H, Doi M, Iso H, Sato S, et al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation. 1989; 79(3): 503-15[PubMed]
  • 17. Stokes J3, Kannel WB, Wolf PA, Cupples LA, D'Agostino RB. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation. 1987; 75(6 Pt 2)-73[PubMed]
  • 18. Sarrafzadegan N, Talaei M, Sadeghi M, Kelishadi R, Oveisgharan S, Mohammadifard N, et al. The Isfahan cohort study: rationale, methods and main findings. J Hum Hypertens. 2011; 25(9): 545-53[DOI][PubMed]
  • 19. Sarraf-Zadegan N, Sadri G, Malek Afzali H, Baghaei M, Mohammadi Fard N, Shahrokhi S, et al. Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. Design, methods and initial experience. Acta Cardiol. 2003; 58(4): 309-20[PubMed]
  • 20. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc. 2001; 285(19): 2486-97[DOI]
  • 21. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ. 2003; 326(7382): 219[PubMed]
  • 22. Kleinman LC, Norton EC. What's the Risk? A simple approach for estimating adjusted risk measures from nonlinear models including logistic regression. Health Serv Res. 2009; 44(1): 288-302[DOI][PubMed]
  • 23. Yano K, Reed DM, McGee DL. Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biologic and lifestyle characteristics. Am J Epidemiol. 1984; 119(5): 653-66[PubMed]
  • 24. Khosravi A, Pourmoghaddas M, Kelishadi R, Sabet B, Ansari R, Shirani S. Trends in Blood Pressure Level, Prevalence of Hypertention and its Care in Isfahan. Iranian Red Crescent Med J. 2005; 2006(2): 62-8
  • 25. Gee ME, Campbell N, Sarrafzadegan N, Jafar T, Khalsa TK, Mangat B, et al. Standards for the uniform reporting of hypertension in adults using population survey data: recommendations from the World Hypertension League Expert Committee. J Clin Hypertens (Greenwich). 2014; 16(11): 773-81[DOI][PubMed]
  • 26. Khosravi A, Ansari R, Shirani S, Baghaei AM. Causes of uncontrolled Blood Pressure in the Over-65 population 2010. ARYA Atheroscler. 2010; 1(2)
  • 27. Khosravi A, Pourheidar B, Roohafza H, Moezzi M, Mousavi M, Hajiannejad A, et al. Evaluating factors associated with uncontrolled hypertension: Isfahan cohort study, Iran. ARYA Atheroscler. 2014; 10(6): 311-8[PubMed]
  • 28. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol. 2005; 162(10): 975-82[DOI][PubMed]
  • 29. Lilly LS. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 2012;
  • 30. Roohafza H, Sadeghi M, Shahnam M, Bahonar A, Sarafzadegan N. Perceived factors related to cigarette and waterpipe (ghelyan) initiation and maintenance in university students of Iran. Int J Public Health. 2011; 56(2): 175-80[DOI][PubMed]
  • 31. Solhpour A, Parkhideh S, Sarrafzadegan N, Asgary S, Williams K, Jungner I, et al. Levels of lipids and apolipoproteins in three cultures. Atherosclerosis. 2009; 207(1): 200-7[DOI][PubMed]
  • 32. Iso H, Sato S, Kitamura A, Imano H, Kiyama M, Yamagishi K, et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke. 2007; 38(6): 1744-51[DOI][PubMed]
  • 33. Chei CL, Yamagishi K, Tanigawa T, Kitamura A, Imano H, Kiyama M, et al. Metabolic Syndrome and the Risk of Ischemic Heart Disease and Stroke among Middle-Aged Japanese. Hypertens Res. 2008; 31(10): 1887-94[DOI][PubMed]
  • 34. Schnohr P, Jensen JS, Scharling H, Nordestgaard BG. Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12 000 men and women from The Copenhagen City Heart Study. Eur Heart J. 2002; 23(8): 620-6[DOI][PubMed]
  • 35. Iso H, Imano H, Kitamura A, Sato S, Naito Y, Tanigawa T, et al. Type 2 diabetes and risk of non-embolic ischaemic stroke in Japanese men and women. Diabetologia. 2004; 47(12): 2137-44[DOI][PubMed]
  • 36. Soyama Y, Miura K, Morikawa Y, Nishijo M, Nakanishi Y, Naruse Y, et al. High-density lipoprotein cholesterol and risk of stroke in Japanese men and women: the Oyabe Study. Stroke. 2003; 34(4): 863-8[DOI][PubMed]
  • 37. Iso H, Naito Y, Sato S, Kitamura A, Okamura T, Sankai T, et al. Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol. 2001; 153(5): 490-9[PubMed]
  • 38. Kitamura A, Iso H, Naito Y, Iida M, Konishi M, Folsom AR, et al. High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation. 1994; 89(6): 2533-9[PubMed]
  • 39. Shimozato M, Nakayama T, Yokoyama T, Yoshi-ike N, Yamaguchi M, Date C. A 15.5-year cohort study on risk factors for possible myocardial infarction and sudden death within 24 hours in a rural Japanese community. J Epidemiol. 1996; 6(1): 15-22[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader